TIMEL: Deep learning-statistical integration reveals spatial stromal and immune signatures of aggressive colon cancer.
Journal:
Journal of pathology informatics
Published Date:
May 12, 2026
Abstract
BACKGROUND: Characterizing the tumor immune microenvironment (TIME) is essential for understanding anti-tumoral responses in colon cancer. This study introduces TIME Landscaper (TIMEL), a computational framework that uses deep learning to identify tissue structures at the microscopic level and summarizes their distribution across whole-slide images (WSIs) using statistical descriptors reflecting intratumoral heterogeneity for prognostic biomarker discovery. METHODS: The performance of six deep learning image classification models (Inception V3, DenseNet-121, ViT-base, UNI, Prov-GigaPath, and Virchow) was evaluated to segment microarchitectural tumor, stromal, and immune areas using nearly 50,000 mini-patches. The selected model was applied to WSIs from discovery (TCGA-COAD; n = 411) and validation (Dartmouth; n = 108) cohorts, segmenting these components to map their spatial distribution. From these maps, 30 statistical descriptors representing abundance, variation, shape, spatial smoothness, and spatial heterogeneity were calculated as slide-level TIMEL features. Univariate and multivariate regression analyses identified survival-associated and metastasis-related biomarkers from the discovery and validation cohorts, respectively. RESULTS: Virchow outperformed other models in segmenting tissue compartments (AUCs: 0.99, 0.98, 0.98 for tumor, stromal, immune components). Slide-level stromal and immune variance correlated with pathologist-assessed metrics (R = 0.47 and 0.32, both p < 0.001). Spatial immune clustering predicted poorer survival (HR = 2.73; p < 0.001), whereas tumor clustering was protective (HR = 0.23; p = 0.001). Tumor spatial smoothness was associated with nodal metastasis (OR = 1.65; p = 0.02). CONCLUSION: TIMEL integrates deep learning and statistics to capture histological heterogeneity within the TIME, enhancing prognostic assessment and supporting precision oncology from routine histology.
Authors
Keywords
No keywords available for this article.